ALPS ADVISORS INC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$9,331,000
+33.0%
382,739
-22.3%
0.07%
+22.2%
Q4 2018$7,017,000
+23.3%
492,427
+31.5%
0.05%
+45.9%
Q3 2018$5,693,000
+11.5%
374,570
+23.1%
0.04%
+12.1%
Q2 2018$5,104,000
+12.3%
304,200
+9.2%
0.03%
-8.3%
Q1 2018$4,545,000
+62.6%
278,488
+27.6%
0.04%
+89.5%
Q4 2017$2,795,000
+34.6%
218,328
+29.3%
0.02%
+26.7%
Q3 2017$2,077,000
+61.0%
168,843
+9.5%
0.02%
+66.7%
Q2 2017$1,290,000154,1700.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders